Just like the opioid manufacturer’s getting money from addiction treatment medications, the manufacturers of cigarettes are capitalizing on asthma and COPD

Just like the opioid manufacturer’s getting money from addiction treatment medications, the manufacturers of cigarettes are capitalizing on asthma and COPD

October 7, 2021
Summary: Philip Morris acquired several healthcare companies in the last few years, including asthma inhaler producer Vectura for $1.52 billion. Though, its primary business comes from the sales of cigarettes and vaping pods. Cigarette smoking and vaping are well known to cause COPD, asthma, and…